These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 22722320)
1. Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopy. Eirich J; Burkhart JL; Ullrich A; Rudolf GC; Vollmar A; Zahler S; Kazmaier U; Sieber SA Mol Biosyst; 2012 Aug; 8(8):2067-75. PubMed ID: 22722320 [TBL] [Abstract][Full Text] [Related]
2. Simplified pretubulysin derivatives and their biological effects on cancer cells. Kubisch R; von Gamm M; Braig S; Ullrich A; Burkhart JL; Colling L; Hermann J; Scherer O; Müller R; Werz O; Kazmaier U; Vollmar AM J Nat Prod; 2014 Mar; 77(3):536-42. PubMed ID: 24437936 [TBL] [Abstract][Full Text] [Related]
3. Identification of a new microtubule-interacting protein Mip-90. González M; Cambiazo V; Maccioni RB Eur J Cell Biol; 1995 Jun; 67(2):158-69. PubMed ID: 7664757 [TBL] [Abstract][Full Text] [Related]
4. Miniaturization and validation of a sensitive multiparametric cell-based assay for the concomitant detection of microtubule-destabilizing and microtubule-stabilizing agents. Vassal E; Barette C; Fonrose X; Dupont R; Sans-Soleilhac E; Lafanechère L J Biomol Screen; 2006 Jun; 11(4):377-89. PubMed ID: 16751334 [TBL] [Abstract][Full Text] [Related]
5. Fluorescent taxoids as probes of the microtubule cytoskeleton. Evangelio JA; Abal M; Barasoain I; Souto AA; Lillo MP; Acuña AU; Amat-Guerri F; Andreu JM Cell Motil Cytoskeleton; 1998; 39(1):73-90. PubMed ID: 9453715 [TBL] [Abstract][Full Text] [Related]
6. Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly. Osiecka KM; Nieznanska H; Skowronek KJ; Karolczak J; Schneider G; Nieznanski K Proteins; 2009 Nov; 77(2):279-96. PubMed ID: 19422054 [TBL] [Abstract][Full Text] [Related]
7. Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity. Acharya BR; Choudhury D; Das A; Chakrabarti G Biochemistry; 2009 Jul; 48(29):6963-74. PubMed ID: 19527023 [TBL] [Abstract][Full Text] [Related]
8. Microtubule-interfering activity of parthenolide. Miglietta A; Bozzo F; Gabriel L; Bocca C Chem Biol Interact; 2004 Oct; 149(2-3):165-73. PubMed ID: 15501437 [TBL] [Abstract][Full Text] [Related]
9. Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy. Herrmann J; Elnakady YA; Wiedmann RM; Ullrich A; Rohde M; Kazmaier U; Vollmar AM; Müller R PLoS One; 2012; 7(5):e37416. PubMed ID: 22616003 [TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives. Rath S; Liebl J; Fürst R; Ullrich A; Burkhart JL; Kazmaier U; Herrmann J; Müller R; Günther M; Schreiner L; Wagner E; Vollmar AM; Zahler S Br J Pharmacol; 2012 Nov; 167(5):1048-61. PubMed ID: 22595030 [TBL] [Abstract][Full Text] [Related]
11. Biophysical characterization of the interactions of HTI-286 with tubulin heterodimer and microtubules. Krishnamurthy G; Cheng W; Lo MC; Aulabaugh A; Razinkov V; Ding W; Loganzo F; Zask A; Ellestad G Biochemistry; 2003 Nov; 42(46):13484-95. PubMed ID: 14621994 [TBL] [Abstract][Full Text] [Related]
12. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability. Poruchynsky MS; Kim JH; Nogales E; Annable T; Loganzo F; Greenberger LM; Sackett DL; Fojo T Biochemistry; 2004 Nov; 43(44):13944-54. PubMed ID: 15518543 [TBL] [Abstract][Full Text] [Related]
13. The natural naphthoquinone plumbagin exhibits antiproliferative activity and disrupts the microtubule network through tubulin binding. Acharya BR; Bhattacharyya B; Chakrabarti G Biochemistry; 2008 Jul; 47(30):7838-45. PubMed ID: 18597479 [TBL] [Abstract][Full Text] [Related]
14. Two photoaffinity analogues of the tripeptide, hemiasterlin, exclusively label alpha-tubulin. Nunes M; Kaplan J; Wooters J; Hari M; Minnick AA; May MK; Shi C; Musto S; Beyer C; Krishnamurthy G; Qiu Y; Loganzo F; Ayral-Kaloustian S; Zask A; Greenberger LM Biochemistry; 2005 May; 44(18):6844-57. PubMed ID: 15865430 [TBL] [Abstract][Full Text] [Related]
15. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action. Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and antitumor activity evaluation of pretubulysin analogs. Xu X; Fan M; Qi J; Yao L Chem Biol Drug Des; 2021 Sep; 98(3):341-351. PubMed ID: 33930251 [TBL] [Abstract][Full Text] [Related]
18. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin. Rappl C; Barbier P; Bourgarel-Rey V; Grégoire C; Gilli R; Carre M; Combes S; Finet JP; Peyrot V Biochemistry; 2006 Aug; 45(30):9210-8. PubMed ID: 16866367 [TBL] [Abstract][Full Text] [Related]